Anticancer Effects of Chenopodium ambrosiodes L. Essential Oil on Human Breast Cancer MCF-7 Cells In vitro
Abstract
Purpose: To investigate the most effective compound of C. ambrosioides essential oil for the induction of cell death in human breast cancer cells (MCF-7), and the mechanism of induction.
Methods: MCF-7 cells were treated with essential oil and its two main components, 1-isopropyl-4- methylbenzene and α-terpinene, respectively, for 24 and 48 h in vitro. To determine their cytotoxicity on MCF-7 cells, in vitro cytotoxicity, 3-(4, 5-dimethylthaizol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) assay and live/dead cell fluorescent staining were used. MCF-7 cellular superoxide dismutase (SOD), catalase (CAT) vitality and malondialdehyde (MDA) content were also evaluated.
Results: MTT results showed that essential oil and its two main compositions significantly inhibited the growth of MCF-7 cells in 24 h (p < 0.05), which was consistent with the Live/dead cell fluorescent staining results. After 24 h incubation the average inhibition rate is 58.98 % for essential oil, 37.8 % for 1-isopropyl-4-methylbenzene and 32.09 % for α-terpinene. With increase in the concentration of essential oil and the two main components, the relative activity of SOD significantly decreased (p < 0.05), while the relative activity of CAT was gradually increased (p < 0.05), compared with control. MDA relative content significantly increased (p < 0.05) until the concentration was 1.25, 0.21 and 0.17 μg/ml for essential oil , 1-isopropyl-4-methylbenzene and α-terpinene , and thereafter significantly decreased (p < 0.05) , compared to control.
Conclusion: The data suggest that the essential oil of C. ambrosioides and its two main components inhibit MCF-7 cell proliferation cell death by inducing oxidative damage. However, the two main components are less effective in their anticancer activity than the essential oil
Keywords: Chenopodium ambrosioides L. Essential oil, 1-isopropyl-4-methylbenzene, α-Terpinene, Breast cancer MCF-7 cells, Antitumor activity
Submission of a manuscript to this journal is a representation that the manuscript has not been published previously and is not under consideration for publication elsewhere.
All authors named in each manuscript would be required to sign a form (to be supplied by the Editor) so that they may retain their copyright in the article but to assign to us (the Publishers) and its licensees in perpetuity, in all forms, formats and media (whether known or created in the future) to (i) publish, reproduce, distribute, display and store the contribution, (ii) translate the contribution into other languages, create adaptations, reprints, include within collections and create summaries, extracts and/or abstracts of the contribution, (iii) create any other derivative works(s) based on the contribution, (iv) to exploit all subsidiary rights in the contribution, (v) the inclusion of electronic links from the contribution to third party material where-ever it may be located, and (vi) license any thrid party to do any or all of the above.
